pubmed-article:20040053 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:20040053 | lifeskim:mentions | umls-concept:C0220847 | lld:lifeskim |
pubmed-article:20040053 | lifeskim:mentions | umls-concept:C0042769 | lld:lifeskim |
pubmed-article:20040053 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
pubmed-article:20040053 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
pubmed-article:20040053 | lifeskim:mentions | umls-concept:C2239176 | lld:lifeskim |
pubmed-article:20040053 | lifeskim:mentions | umls-concept:C0021641 | lld:lifeskim |
pubmed-article:20040053 | lifeskim:mentions | umls-concept:C0038766 | lld:lifeskim |
pubmed-article:20040053 | lifeskim:mentions | umls-concept:C0205217 | lld:lifeskim |
pubmed-article:20040053 | lifeskim:mentions | umls-concept:C0004083 | lld:lifeskim |
pubmed-article:20040053 | lifeskim:mentions | umls-concept:C0021149 | lld:lifeskim |
pubmed-article:20040053 | lifeskim:mentions | umls-concept:C0205228 | lld:lifeskim |
pubmed-article:20040053 | pubmed:issue | 3 | lld:pubmed |
pubmed-article:20040053 | pubmed:dateCreated | 2010-5-11 | lld:pubmed |
pubmed-article:20040053 | pubmed:abstractText | Diabetes mellitus is frequently seen in hepatitis C patients and is often treated with antidiabetic agents that increase serum insulin levels. Because insulin is a growth-promoting hormone, antidiabetic agents could pose a risk for hepatocellular carcinoma (HCC). | lld:pubmed |
pubmed-article:20040053 | pubmed:language | eng | lld:pubmed |
pubmed-article:20040053 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20040053 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:20040053 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20040053 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20040053 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20040053 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:20040053 | pubmed:month | Mar | lld:pubmed |
pubmed-article:20040053 | pubmed:issn | 1478-3231 | lld:pubmed |
pubmed-article:20040053 | pubmed:author | pubmed-author:KawaguchiTaku... | lld:pubmed |
pubmed-article:20040053 | pubmed:author | pubmed-author:SataMichioM | lld:pubmed |
pubmed-article:20040053 | pubmed:author | pubmed-author:TaniguchiEita... | lld:pubmed |
pubmed-article:20040053 | pubmed:author | pubmed-author:NagataEisukeE | lld:pubmed |
pubmed-article:20040053 | pubmed:author | pubmed-author:MoritaYasuyoY | lld:pubmed |
pubmed-article:20040053 | pubmed:author | pubmed-author:TateishiIkuoI | lld:pubmed |
pubmed-article:20040053 | pubmed:author | pubmed-author:ShirachiMikiM | lld:pubmed |
pubmed-article:20040053 | pubmed:issnType | Electronic | lld:pubmed |
pubmed-article:20040053 | pubmed:volume | 30 | lld:pubmed |
pubmed-article:20040053 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:20040053 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:20040053 | pubmed:pagination | 479-86 | lld:pubmed |
pubmed-article:20040053 | pubmed:dateRevised | 2011-11-17 | lld:pubmed |
pubmed-article:20040053 | pubmed:meshHeading | pubmed-meshheading:20040053... | lld:pubmed |
pubmed-article:20040053 | pubmed:meshHeading | pubmed-meshheading:20040053... | lld:pubmed |
pubmed-article:20040053 | pubmed:meshHeading | pubmed-meshheading:20040053... | lld:pubmed |
pubmed-article:20040053 | pubmed:meshHeading | pubmed-meshheading:20040053... | lld:pubmed |
pubmed-article:20040053 | pubmed:meshHeading | pubmed-meshheading:20040053... | lld:pubmed |
pubmed-article:20040053 | pubmed:meshHeading | pubmed-meshheading:20040053... | lld:pubmed |
pubmed-article:20040053 | pubmed:meshHeading | pubmed-meshheading:20040053... | lld:pubmed |
pubmed-article:20040053 | pubmed:meshHeading | pubmed-meshheading:20040053... | lld:pubmed |
pubmed-article:20040053 | pubmed:meshHeading | pubmed-meshheading:20040053... | lld:pubmed |
pubmed-article:20040053 | pubmed:meshHeading | pubmed-meshheading:20040053... | lld:pubmed |
pubmed-article:20040053 | pubmed:meshHeading | pubmed-meshheading:20040053... | lld:pubmed |
pubmed-article:20040053 | pubmed:meshHeading | pubmed-meshheading:20040053... | lld:pubmed |
pubmed-article:20040053 | pubmed:year | 2010 | lld:pubmed |
pubmed-article:20040053 | pubmed:articleTitle | Association of exogenous insulin or sulphonylurea treatment with an increased incidence of hepatoma in patients with hepatitis C virus infection. | lld:pubmed |
pubmed-article:20040053 | pubmed:affiliation | Department of Digestive Disease Information & Research, Division of Gastroenterology, Kurume University School of Medicine, Kurume, Japan. takumi@med.kurume-u.ac.jp | lld:pubmed |
pubmed-article:20040053 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:20040053 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:20040053 | lld:pubmed |